Unknown

Dataset Information

0

A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen.


ABSTRACT: Members of the Flaviviridae family are the leading causes of mosquito-borne viral disease worldwide. While dengue virus is the most prevalent, the recent Zika virus outbreak in the Americas triggered a WHO public health emergency, and yellow fever and West Nile viruses (WNV) continue to cause regional epidemics. Given the sporadic nature of flaviviral epidemics both temporally and geographically, there is an urgent need for vaccines that can rapidly provide effective immunity. Protection from flaviviral infection is correlated with antibodies to the viral envelope (E) protein, which encodes receptor binding and fusion functions. TLR agonist adjuvants represent a promising tool to enhance the protective capacity of flavivirus vaccines through dose and dosage reduction and broadening of antiviral antibody responses. This study investigates the ability to improve the immunogenicity and protective capacity of a promising clinical-stage WNV recombinant E-protein vaccine (WN-80E) using a novel combination adjuvant, which contains a potent TLR-4 agonist and the saponin QS21 in a liposomal formulation (SLA-LSQ). Here, we show that, in combination with WN-80E, optimized SLA-LSQ is capable of inducing long-lasting immune responses in preclinical models that provide sterilizing protection from WNV challenge, reducing viral titers following WNV challenge to undetectable levels in Syrian hamsters. We have investigated potential mechanisms of action by examining the antibody repertoire generated post-immunization. SLA-LSQ induced a more diverse antibody response to WNV recombinant E-protein antigen than less protective adjuvants. Collectively, these studies identify an adjuvant formulation that enhances the protective capacity of recombinant flavivirus vaccines.

SUBMITTER: Van Hoeven N 

PROVIDER: S-EPMC6158298 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen.

Van Hoeven Neal N   Wiley Steven S   Gage Emily E   Fiore-Gartland Andrew A   Granger Brian B   Gray Sean S   Fox Christopher C   Clements David E DE   Parks D Elliot DE   Winram Scott S   Stinchcomb Dan T DT   Reed Steven G SG   Coler Rhea N RN  

NPJ vaccines 20180926


Members of the <i>Flaviviridae</i> family are the leading causes of mosquito-borne viral disease worldwide. While dengue virus is the most prevalent, the recent Zika virus outbreak in the Americas triggered a WHO public health emergency, and yellow fever and West Nile viruses (WNV) continue to cause regional epidemics. Given the sporadic nature of flaviviral epidemics both temporally and geographically, there is an urgent need for vaccines that can rapidly provide effective immunity. Protection  ...[more]

Similar Datasets

| S-EPMC4762984 | biostudies-literature
| S-EPMC3880254 | biostudies-literature
| S-EPMC1436023 | biostudies-literature
| S-EPMC4766991 | biostudies-literature
| S-EPMC8552335 | biostudies-literature
| S-EPMC3424137 | biostudies-literature
2016-09-01 | GSE86000 | GEO
| S-EPMC5800658 | biostudies-literature
| S-EPMC2820154 | biostudies-literature
| S-EPMC3773989 | biostudies-other